August 25, 2026 06:13 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘Reservation for poor, not caste’: Stir at Delhi’s Jantar Mantar | Dalit woman 'gangrape-murder' shocker in Karnataka: 4 arrested after body found in well | India dismisses Pakistan's 'frustration' over US envoy's J&K remark | Centre denies US visit clearance to Telangana CM Revanth Reddy, says programmes 'not appropriate' | Delhi Police register FIR in pellet gun case after Rahul Gandhi's sit-in | Rahul Gandhi stages dharna at Delhi police station over CJP protest crackdown, targets Amit Shah | CJP school tour turns chaotic in Jaipur: Cars vandalised, stones pelted as Ashutosh Ranka alleges BJP ‘goons’ attack | Vande Mataram row: Kangana Ranaut slams Sharmila Tagore, says ‘come out of Hindu-Muslim mindset’ | Jadavpur erupts again: ABVP-SFI clash, police barricades shattered as fresh tension grips area | Ex-Congress MP and 1984 anti-Sikh riots convict Sajjan Kumar dies while serving life sentence

Dexamethasone proves life-saving drug for COVID-19 patients: UK experts

| @indiablooms | Jun 16, 2020, at 08:15 pm

London/IBNS: Amid the deteriorating condition worldwide, experts in the United Kingdom have suggested that treating Coronavirus patients with low doses of the generic steroid drug dexamethasone have been effective in reducing death rates.

According to new trial data published on Tuesday, the drug had reduced death rates by around one-third among those having the most severe conditions due to the infection.

Experts have termed it a 'major breakthrough' in the fight against the deadly virus.

"It cut the risk of death by a third for patients on ventilators. For those on oxygen, it cut deaths by a fifth," a BBC report said.

The drug had been a part of experiments to examine if it worked for coronavirus treatments.

Researchers noted that had the drug been used since the inception of the pandemic in the UK, up to 5000 lives could have been saved.

The drug has a huge potentiality to treat patients in poor countries owing to its cheap price and wide availability.

The UK is the fifth worst-hit country globally with nearly 3 lakh cases and about 42,000 deaths.



 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.